Stockholders' Deficiency (Details Narrative) - USD ($)						1 Months Ended				3 Months Ended			7 Months Ended	9 Months Ended		12 Months Ended
	Jan. 09, 2020	Jan. 09, 2020	Dec. 19, 2019	Feb. 02, 2016	Feb. 02, 2016	Mar. 31, 2020	Oct. 31, 2019	Jul. 31, 2019	May 31, 2019	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2019	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019	Mar. 31, 2020	Mar. 30, 2020	Mar. 31, 2019	Mar. 31, 2018	May 22, 2020	Mar. 31, 2017
Common stock, shares authorized						125,000,000				125,000,000				125,000,000		125,000,000
Common stock, par value						$ 0.001				$ 0.001				$ 0.001		$ 0.001
Preferred stock, shares authorized						10,000,000				10,000,000				10,000,000		10,000,000
Preferred stock, par value						$ 0.001				$ 0.001				$ 0.001		$ 0.001
Common stock, shares issued						32,593,769				34,576,797				34,576,797		32,593,769
Common stock, shares outstanding						32,593,769				34,576,797				34,576,797		32,593,769
Exchangeable shares outstanding						3,788,062				3,219,518				3,219,518		3,788,062
Preferred stock, shares issued						1				1				1		1
Preferred shares outstanding						1				1				1		1
Number of common shares issued, value															$ 28,566
General and administrative and research and development expenses										$ 3,688,868		$ 2,179,928		$ 9,675,299	6,292,225
Accrued preferred stock dividends																	$ 257,927
Dividends paid																	$ 180,000
Issuance of shares for services, value										370,580		158,687		1,877,556	552,848
Research and development expenses										$ 681,411		447,639		$ 1,507,634	879,661
Stock price						$ 0.588				$ 0.76				$ 0.76		$ 0.588
Stock based compensation														$ 482,175	649,587
2016 Equity Incentive Plan [Member]
Number of common stock option exercise
Stock price						0.974										$ 0.974
Number of options authorized to issue				3,750,000	3,750,000
Options exercise price						$ 3.1069				$ 2.3956				$ 2.3956		$ 3.1069		$ 3.1436	$ 3.2306		$ 3.2306
Plan description				The maximum number of shares of stock that may be issued under the Plan shall be equal to 3,750,000 shares; provided that the maximum number of shares of stock that may be issued under the Plan pursuant to awards shall automatically and without any further Company or shareholder approval, increase on January 1 of each year for not more than 10 years from the effective date, so the number of shares that may be issued is an amount no greater than 20% of the Company's outstanding shares of stock and shares of stock underlying any outstanding exchangeable shares as of such January 1; provided further that no such increase shall be effective if it would violate any applicable law or stock exchange rule or regulation, or result in adverse tax consequences to the Company or any participant that would not otherwise result but for the increase.
Number of options granted										519,033				2,376,480		88,100		270,521
Number of options granted, exercise price														$ 0.9787		$ 0.7763
Stock based compensation										$ 13,871		$ 154,996		$ 482,175	$ 493,885	$ 2,408,713
Minimum [Member] | 2016 Equity Incentive Plan [Member]
Risk free rate						0.46%								0.198%
Expected volatility														113.40%
Weighted average remaining contractual life														6 years 6 months		2 years 9 months 3 days
Maximum [Member] | 2016 Equity Incentive Plan [Member]
Risk free rate						0.75%								0.7832%
Expected volatility														123.80%
Weighted average remaining contractual life																9 years 6 months 3 days
Issuance of Common Shares [Member]
Number of common shares issued, shares														1,414,500				972,950
Number of common shares issued, value														$ 1,862,857				$ 666,129
General and administrative and research and development expenses										$ 519,916								$ 835,619
Fair value of common share														791,000
Fair value of common share, value														$ 1,063,754
Issuance of Common Shares [Member] | Advisor [Member]
Number of common shares issued, shares														339,500
Number of common shares issued, value														$ 250,715
Number of common stock option exercise														97,500
Promissory Notes [Member]
Conversion of stock, shares	1,830						1,830						1,945
Conversion of stock	$ 1,830,000
Promissory Notes [Member]
Proceeds from issuance of warrants																$ 92,416
Warrant [Member]
Number of common stock option exercise														97,500
Registered Offering [Member]
Number of common shares issued, shares								47,585	47,585
Proceeds from private offering								$ 28,565	$ 28,565
Various Consultants and Advisors [Member] | Issuance of Common Shares [Member]
Number of common shares issued, shares																		178,750
Number of common shares issued, value																		$ 169,490
Investors [Member] | Common Stock [Member]
Number of common shares issued, shares										540,000						525,023
Number of shares issued for services											290,000
Advisor and Consultant [Member]
General and administrative and research and development expenses																$ 184,637
Number of common stock compensation for services																1,021,430
Number of common stock compensation for services, value																$ 277,053
Advisor and Consultant [Member] | Warrant [Member] | Minimum [Member]
Expected life																2 years
Risk free rate																0.22%
Stock price						$ 0.52				$ 0.7383				$ 0.7383		$ 0.52
Expected volatility																114.30%
Advisor and Consultant [Member] | Warrant [Member] | Maximum [Member]
Expected life																3 years
Risk free rate																1.71%
Stock price						$ 0.974				$ 1.11				1.11		$ 0.974
Expected volatility																132.20%
Advisor and Consultant [Member]
Number of common stock compensation for services										226,667
Number of common stock compensation for services, value										$ 73,729
Expected life										3 years
Advisor and Consultant [Member] | Warrant [Member]
Stock price										$ 0.7383				$ 0.7383
Advisor and Consultant [Member] | Warrant [Member] | Minimum [Member]
Risk free rate										0.198%
Expected volatility										113.40%
Advisor and Consultant [Member] | Warrant [Member] | Maximum [Member]
Risk free rate										0.783%
Expected volatility										123.80%
Advisor and Consultant [Member]
Number of common stock compensation for services														349,584
Number of common stock compensation for services, value														$ 173,523
Advisor and Consultant [Member] | Warrant [Member] | Minimum [Member]
Risk free rate														0.167%
Expected volatility														113.40%
Advisor and Consultant [Member] | Warrant [Member] | Maximum [Member]
Expected life														3 years
Risk free rate														0.783%
Expected volatility														127.60%
Officer [Member]
Consultant warrants shares										788,806				788,806
Board of Director [Member] | 2016 Equity Incentive Plan [Member]
Number of common stock compensation for services, value																$ 1,600,515
Expected life																10 years
Expected volatility																132.20%
Weighted average remaining contractual life																10 years
Director of Company [Member]
Number of options granted														1,400,000
Another Director [Member]
Number of options granted														367,647
Exchange Agreement [Member]
Percentage of common stock issued and outstanding					90.00%
Common stock exchange description					1.197 shares of its common stock in exchange for each common share
Number of common shares issued, shares					13,376,947
Exchange Agreement [Member] | 11% Secured Convertible Promissory Notes [Member]
Conversion description					The outstanding 11% secured convertible promissory notes of the Company were adjusted, in accordance with the adjustment provisions thereof, as and from closing, so as to permit the holders to convert (and in some circumstances permit the Company to force the conversion of) the convertible promissory notes into shares of the common stock of Biotricity at a 25% discount to purchase price per share in Biotricity's next offering.
Discount percentage for purchase price per shares					25.00%
Exchange Agreement [Member] | Warrant [Member]
Common stock exchange description					1.197 shares of the common stock of Biotricity for each Warrant, with an inverse adjustment to the exercise price of the Warrants to reflect the exchange ratio of approximately 1.197:1
Exchange ratio					1.197:1
Exchange Agreement [Member] | Advisor Warrant [Member]
Common stock exchange description					1.197 shares of the common stock of Biotricity for each Advisor Warrant, with an inverse adjustment to the exercise price of the Advisor Warrants to reflect the exchange ratio of approximately 1.197:1
Exchange ratio					1.197:1
Exchange Agreement [Member] | Options [Member]
Common stock exchange description					1.197 economically equivalent replacement options with an inverse adjustment to the exercise price of the replacement option to reflect the exchange ratio of approximately 1.197:1
Exchange ratio					1.197:1
Exchange Agreement [Member] | Exchangeco [Member]
Common stock exchange description
Number of exchangeable shares issued
Issuance of Employee Options [Member] | 2016 Equity Incentive Plan One [Member]
Stock price										$ 0.7383				$ 0.7383
Series A Preferred Stock [Member]
Preferred stock, shares authorized						20,000				20,000				20,000		20,000
Preferred stock, par value						$ 0.001				$ 0.001				$ 0.001		$ 0.001
Preferred stock, shares issued	7,830	7,830	7,830			7,830				8,045			8,045	8,045		7,830				215
Preferred shares outstanding						7,830				8,045				8,045		7,830
Number of common shares issued, shares		6,000	6,000										6,100
Series A Preferred Stock [Member] | Securities Purchase Agreement [Member]
Number of exchangeable shares issued			6,000
Proceeds from private offering			$ 6,000,000
Preferred stock, conversion method on issuance, description			The shares are convertible into common stock of the Company at a conversion price equal to the greater of $0.001 or a 15% discount to the 5-day volume weighted price at the time of conversion. The conversion rights commence 24 months after issuance, but conversion is limited to 5% of the aggregate purchase price of the holder on a monthly basis thereafter. Alternatively, the shares are convertible into common stock at a 15% discount to any qualified future common stock financing conducted by the Company. The Company may redeem the shares after 1 year for 110% of the purchase price plus accrued dividends. The preferred stock bears a dividend rate of 12% per annum